Junipero Therapeutics, Inc.

Funding and NIH signals

• NIH award NIH awarded $307K (STTR Phase I 1R41NS150094-01, new, notice Sep 8, 2026). NIH RePORTER 1R41NS150094-01 (Sep 8, 2026)
  Evidence (1 event)

  • Sep 8, 2026 · NIH RePORTER 1R41NS150094-01
    Organization: JUNIPERO THERAPEUTICS, INC.; City/State: KANNAPOLIS, NC; Project number: 1R41NS150094-01; Activity code: R41; Fiscal year: 2026; Award notice date: 2026-09-08; FY total cost (award amount): 306872; Administering IC: National Institute of Neurological Disorders and Stroke; Project title: Epigenetic Silencing of VCP via an ASO-Conjugate Based Induced Proximity System for the Treatment of FTD-ALS in VCP Disease; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals